Endogenous Anandamide Like Compounds – Raphael Mechoulam, PhD
Raphael Mechoulam, PhD presents “Endogenous Anandamide Like Compounds” at CannMed 2022.
Raphael Mechoulam, PhD presents “Endogenous Anandamide Like Compounds” at CannMed 2022.
Abstract The aggressive behavior of Glioblastoma multiforme (GBM) is mainly due to high invasiveness and proliferation rate as…
Abstract Colon cancer is the third most common human malignancy and a main cause of death worldwide. The…
Abstract Evidence suggests that the nonpsychotropic cannabis-derived compound, cannabidiol (CBD), has antineoplastic activity in multiple types of cancers,…
Abstract The main chemical component of cannabis, cannabidiol (CBD), has been shown to have antitumor properties. The present…
What is CBDV? Learn all about this newly available phytocannabinoid…what it is, who might benefit from its medicinal…